20Writing medication chart prescriptions

20 Writing medication chart prescriptions

Chart is not required to be in approved form (1) A chart used to write a chemotherapy prescription or a prescription for a special arrangement supply of a related pharmaceutical benefit: (a) is not required to be in a form approved under paragraph 41(5)(a) of the Regulations or meet the information requirements approved under paragraph 41(5)(b) of the Regulations; and (b) is taken to be a medication chart for the purposes of the Regulations despite paragraphs 41(4)(a) and (b) of the Regulations. No application to persons receiving treatment in or at residential care services (2) Subparagraph 41(1)(a)(i) of the Regulations does not apply to a medication chart prescription that is: (a) a chemotherapy prescription; or (b) a prescription for a special arrangement supply of a related pharmaceutical benefit. Modified application of section 41 of the Regulations—electronic medication chart prescriptions (3) For an electronic medication chart prescription that is a chemotherapy prescription or a prescription for a special arrangement supply of a related pharmaceutical benefit: (a) paragraph 41(2)(c) of the Regulations does not apply; and (b) the authorised prescriber must approve the prescription in the electronic system used to write the prescription; and (c) paragraph 104(3)(b) of the Regulations does not apply. Modifications for chemotherapy drugs only (4) A medication chart prescription that is a chemotherapy prescription must include the following information: (a) the name of the chemotherapy drug directed to be supplied; (b) the dose of the chemotherapy drug directed to be supplied; (c) the frequency of administration and route of administration of the dose; (d) the date of the prescription. (5) The following provisions of the Regulations do not apply in relation to the writing of a medication chart prescription that is a chemotherapy prescription: (a) subparagraph 41(2)(a)(i) and subsection 41(2A); (b) subparagraph 41(2)(a)(ii); (c) subparagraph 41(2)(a)(iii).

Note: If the prescription does include directions about particular pharmaceutical benefits to be supplied, an approved supplier is not required to follow the prescriber’s directions—see subsection 23(8).